US Stock MarketDetailed Quotes

VYNE VYNE Therapeutics

Watchlist
  • 2.0900
  • -0.0100-0.48%
Close Jul 23 16:00 ET
30.36MMarket Cap-1756P/E (TTM)

VYNE Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

VYNE Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

98.00K

-1.01%
EPS(YoY)

-0.15

+91.38%
Analyst Rating

Buy

Jun 30, 2024

VYNE Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 110.000K--
--2024/Q2-- / 110.000K--
--2024/Q198.000K / 100.000K--
--2023/Q476.000K / 150.000K--
--2023/Q3114.000K / 150.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 110.000K--
--2024/Q2-- / 110.000K--
--2024/Q198.000K / 100.000K--
--2023/Q476.000K / 150.000K--
--2023/Q3114.000K / 150.000K--

Unlock Free Earnings Estimates

VYNE Therapeutics Earnings Reports

  • VYNE Therapeutics | 10-Q: Quarterly report

    May 9 16:05 ET

  • VYNE Therapeutics | 10-K: Annual report

    Mar 1 16:09 ET

  • VYNE Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 07:57 ET

  • VYNE Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 16:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg